A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8+ T Cells Essential for the Protection against Experimental Visceral Leishmaniasis-Reference-Cited by-同舟云学术

A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8+ T Cells Essential for the Protection against Experimental Visceral Leishmaniasis

Published:2017-06-13 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Athanasiou Evita,Agallou Maria,Tastsoglou Spyros,Kammona Olga,Hatzigeorgiou Artemis,Kiparissides Costas,Karagouni Evdokia

Funder

General Secretariat for Research and Technology

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference96 articles.

1. Visceral Leishmaniasis: Control Strategies and Epidemiological Situation Update in East Africa, Report of a WHO Bi-Regional Consultation Addis Ababa, Ethiopia2015

2. WHO leishmaniasis control team leishmaniasis worldwide and global estimates of its incidence;Alvar;PLoS One,2012

3. Epidemiology of visceral leishmaniasis;Ready;Clin Epidemiol,2014

4. Leishmaniasis: complexity at the host-pathogen interface;Kaye;Nat Rev Microbiol,2011

5. Regulation of immunity during visceral Leishmania infection;Rodrigues;Parasit Vectors,2016

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing and development of efficient multi-epitope-based peptide vaccine candidate against emerging avian rotavirus strains: A vaccinomic approach;Journal of Genetic Engineering and Biotechnology;2024-09

2. Novel HER2-based multi-epitope vaccine (HER2-MEV) against HER2-positive breast cancer: In silico design and validation;Human Immunology;2024-07

3. Revolutionizing Leishmaniasis Treatment with Cutting Edge Drug Delivery Systems and Nanovaccines: An Updated Review;ACS Infectious Diseases;2024-06-03

4. In silico design of a novel multi-epitope vaccine against HCV infection through immunoinformatics approaches;International Journal of Biological Macromolecules;2024-05

5. Targeted and Self-Adjuvated Nanoglycovaccine Candidate for Cancer Immunotherapy;ACS Nano;2024-03-27